Device / Technology News

RSS

Life Technologies debuts Invitrogen MAGic Sample Processor for addressing reproducibility challenges

Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.

26 Apr 2010

OICR makes equity investments in three promising Ontario technologies

Frank Stonebanks, Vice-President, Commercialization and Chief Commercial Officer of the Ontario Institute for Cancer Research today announced that OICR has made equity investments in three promising Ontario technologies to accelerate their commercialization.

26 Apr 2010

Bruker to supply customized N8 TITANOS large sample AFM to US Commerce Department's NIST

Bruker today announced that it has been awarded a $1.1 million contract to supply a customized N8 TITANOS™ large sample Atomic Force Microscope (AFM) to the United States Commerce Department's National Institute of Standards and Technology (NIST). The instrument will be used by NIST's Precision Engineering Division (PED) at its Manufacturing Engineering Laboratory, with a main focus on metrology applications which require traceable AFM (T-AFM).

26 Apr 2010

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.

26 Apr 2010

IRIS International announces renewal of supply agreement with MedAssets Supply Chain Systems

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that it has renewed a supply agreement for its full product line of automated and semi-automated urinalysis systems, related products, consumables and services agreements, with MedAssets Supply Chain Systems, one of the largest Group Purchasing Organizations (GPOs) serving healthcare providers nationwide. The new three-year contract is effective April 1, 2010.

26 Apr 2010

Medtronic receives FDA 510(K) clearance for PoleStar N30 Surgical MRI system

Medtronic today announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.

26 Apr 2010

SQI Diagnostics signs development agreement with Silliker

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that it has entered into a development agreement with Silliker, Inc., a leading internationally accredited company dedicated to improving nutrition, food safety and quality, for the commercialization of a botulism toxin panel that will run on SQI's SQiDman analytical system.

26 Apr 2010

Study confirms utility of Oxford Immunotec's T-SPOT.TB assay in identifying latent TB infection

The authors of a recent peer-reviewed study published in the International Journal of Tuberculosis and Lung Disease confirmed the high specificity of the T-SPOT.TB assay.

26 Apr 2010

Investment report featuring Imaging3

MicroStockProfit.com announces an investment report featuring Imaging3 Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

26 Apr 2010

Kinetic Concepts introduces V.A.C.Via Therapy System

Kinetic Concepts, Inc. today introduced V.A.C.Via Therapy System, a next-generation negative pressure wound therapy solution that offers clinicians and patients a mobile healing technology with the proven benefits and outcomes of V.A.C. Therapy.

26 Apr 2010

ev3 completes enrollment in study of EverFlex Self-Expanding Stent System for SFA

ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.

26 Apr 2010

Reconstructive techniques for degenerative mitral valve disease

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the release of a brand-new single volume comprehensive book on reconstructive techniques for degenerative mitral valve disease by the internationally renowned cardiac surgeon and educator, Dr. Alain Carpentier. The book will launch at the 90th Annual Meeting of the American Association for Thoracic Surgery at the Metro Toronto Convention Centre in Toronto, Ontario, Canada, May 1 - 5, 2010.

26 Apr 2010

Beijing Customs seize Biosite's Triage products

Biosite's Triage products imported by Inverness Medical Beijing Co., Ltd. in April 2010 have been seized by Beijing Customs for not complying with the applicable importation regulations. As a result, the Chinese market is facing a severe shortage.

26 Apr 2010

Vitamin selected as agency of record for IZI Medical Products

The boutique design-web-public relations firm Vitamin® announced today its selection as agency of record for IZI Medical Products, a Maryland-based innovator of medical device accessories. Vitamin is providing IZI with retained public relations services for strengthening overall brand and key product awareness. Additionally, Vitamin is handling product naming and product branding, as well as integrated marketing for refreshing IZI's new corporate messaging, tagline and logo.

26 Apr 2010

Ness Technologies announces implementation of Oracle E-Business Suite at Teva Czech Industries

Ness Technologies, Inc., a global provider of information technology solutions and services, announced today the start of an Oracle E-Business Suite implementation at Teva Czech Industries s.r.o., a provider of pharmaceutical products. The new system will handle financial and logistics issues, replacing a current QAD MFG/Pro system.

26 Apr 2010

Bowel cancer screening programme launched in Northern Ireland

The bowel cancer screening programme, which detects early signs of the disease, has been launched in Northern Ireland.

26 Apr 2010

U.S. DOE awards Verenium additional $4.9M for development of cellulosic ethanol biorefinery plants

Verenium Corporation, a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has been awarded an additional $4.9 million from the U.S. Department of Energy (DOE) to fund ongoing activities at its demonstration-scale facility in Jennings, Louisiana.

26 Apr 2010

Mimicking human nervous system for bionic applications can become a reality: Researchers

Mimicking the human nervous system for bionic applications could become a reality with the help of a method developed at Oak Ridge National Laboratory to process carbon nanotubes.

26 Apr 2010

Anacor Pharmaceuticals, MMV partner to discover and develop promising new malaria therapeutics

Anacor Pharmaceuticals today announced that it has entered into a research agreement with not-for-profit Medicines for Malaria Venture (MMV) to explore Anacor's novel boron chemistry platform for developing new therapeutics for the treatment of malaria. Under the agreement, Anacor will be responsible for leading the research effort and MMV will contribute its extensive malaria drug research expertise as well as financial support.

26 Apr 2010

GE Healthcare commits to reduce average energy consumption of ultrasound products by 25%

GE Healthcare, a business unit of General Electric Company, announced today a commitment to reduce the average energy consumption of new ultrasound products by 25 percent by 2012.

26 Apr 2010

Device / Technology News

Life Technologies debuts Invitrogen MAGic Sample Processor for addressing reproducibility challenges

OICR makes equity investments in three promising Ontario technologies

Bruker to supply customized N8 TITANOS large sample AFM to US Commerce Department's NIST

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

IRIS International announces renewal of supply agreement with MedAssets Supply Chain Systems

Medtronic receives FDA 510(K) clearance for PoleStar N30 Surgical MRI system

SQI Diagnostics signs development agreement with Silliker

Study confirms utility of Oxford Immunotec's T-SPOT.TB assay in identifying latent TB infection

Investment report featuring Imaging3

Kinetic Concepts introduces V.A.C.Via Therapy System

ev3 completes enrollment in study of EverFlex Self-Expanding Stent System for SFA

Reconstructive techniques for degenerative mitral valve disease

Beijing Customs seize Biosite's Triage products

Vitamin selected as agency of record for IZI Medical Products

Ness Technologies announces implementation of Oracle E-Business Suite at Teva Czech Industries

Bowel cancer screening programme launched in Northern Ireland

U.S. DOE awards Verenium additional $4.9M for development of cellulosic ethanol biorefinery plants

Mimicking human nervous system for bionic applications can become a reality: Researchers

Anacor Pharmaceuticals, MMV partner to discover and develop promising new malaria therapeutics

GE Healthcare commits to reduce average energy consumption of ultrasound products by 25%

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News